Polycythemia Vera Archives - Oncology Nurse Advisor

Polycythemia Vera

Ruxolitinib (Jakafi)

This slideshow reviews ruxolitinib (Jakafi), indicated for intermediate or high-risk myelofibrosis, and polycythemia vera in cases of inadequate response or intolerance of hydroxyurea. Table of Contents Slide 4: Dosage and AdministrationSlide 17: Cautions, Effects, and InteractionsSlide 24: What to Tell Your PatientSlide 29: Reference

Next post in Myeloproliferative Neoplasms